Curevo Vaccine (Curevo), a privately-held clinical-stage biotechnology company dedicated to developing varicella zoster virus (VZV) vaccines with improved tolerability and accessibility, today ...
95% of adults in the US carry the latent virus and are therefore susceptible to shingles. The symptoms of HZ typically last 2-4 weeks and the clinical presentation is characterized by a unilateral ...